Daily Archives: April 24, 2012

An STD superbug?

By on .

Capitol Hill briefing sheds light on imminent emergence of drug-resistant gonorrhea

Testament to “too many years of neglect of investments in sexually transmitted diseases (STDs),” a gonorrhea superbug is expected to make its appearance in the U.S. within the near future. That’s according to a panel of experts that spoke at a Capitol Hill briefing Friday hosted by Rep. Barbara Lee’s (D-CA) office along with the National Coalition of STD Directors…

Malawi and Option B Plus

By on .

Despite its status as one of the poorest countries in Africa and its failed effort to garner a Round 10 grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria – Malawi is moving forward to implement “Option B+” for pregnant women.  This means that pregnant and lactating women are enrolled in antiretroviral therapy […]

HIV treatment optimization and The Bill & Melinda Gates Foundation

By on .

Stephen Becker from The Bill & Melinda Gates Foundation updated the participants of the International Treatment as Prevention conference in Vancouver about the Foundation’s treatment optimization activities on Tuesday.  This initiative was conceived within the context of combination prevention and treatment and a constrained funding environment that does not permit treatment for all who need […]

CHAI finds low health care facility costs for HIV treatment

By on .

Kate Condliffe from the Clinton Health Access Initiative (CHAI) presented a very interesting costing study at the International HIV Treatment as Prevention meeting in Vancouver Monday. The study analyzed the cost of providing antiretroviral therapy (ART) at the facility level at 161 representative facilities in Ethiopia, Malawi, Rwanda, South Africa and Zambia.  This was a […]